Draft Whole-Genome Sequences of 51 Campylobacter jejuni and 12 Campylobacter coli Clinical Isolates from Chile.

Microbiol Resour Announc

Center for Food Safety and Applied Nutrition, Office of Regulatory Science, Division of Microbiology, U.S. Food and Drug Administration, College Park, Maryland, USA

Published: April 2020

species are the leading cause of gastroenteritis worldwide and an emerging threat in developing countries. Here, we report the draft whole-genome sequences of 51 and 12 strains isolated from patients with gastroenteritis in Santiago, Chile.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193920PMC
http://dx.doi.org/10.1128/MRA.00072-20DOI Listing

Publication Analysis

Top Keywords

draft whole-genome
8
whole-genome sequences
8
sequences campylobacter
4
campylobacter jejuni
4
jejuni campylobacter
4
campylobacter coli
4
coli clinical
4
clinical isolates
4
isolates chile
4
chile species
4

Similar Publications

While studying the prevalence and profile of antibiotic resistance among isolated from the feces of calves with signs of colibacillosis, a strain with a wide spectrum of drug resistance was isolated. Whole-genome sequencing, followed by bioinformatic processing and the annotation of genes of this strain, showed that the genome has a total length of 4,803,482 bp and contains 4986 genes, including 122 RNA genes. A total of 31% of the genes are functionally significant and represent 26 functional groups.

View Article and Find Full Text PDF

: Infections caused by multidrug-resistant (MDR)bacteria pose a significant public health threat by worsening patient outcomes, contributing to hospital outbreaks, and increasing health and economic burdens. Advanced genomic tools enhance the detection of resistance genes, virulence factors, and high-risk clones, thus improving the management of MDR infections. In the Autonomous Community of Aragon, the diversity and incidence of carbapenemase-producing Enterobacteriaceae (CPE) have increased during the last years.

View Article and Find Full Text PDF

Draft genome sequence of sp. CC302I with non-canonical biosynthetic gene clusters for codon-readthrough activity.

Microbiol Resour Announc

January 2025

Industrial Genomics Laboratory, FEMSA Biotechnolgy Center, School of Engineering and Sciences, Tecnológico de Monterrey, Monterrey, México.

sp. CC302I was isolated from a highly oligothrophic environment. High-throughput screening shows high codon-readthrough activity for the isolate with no canonical biosynthetic gene cluster responsible.

View Article and Find Full Text PDF

The draft genome sequence of DS1 was isolated for high-acidity vinegar fermentation. The DS1 draft genome has a length of 8,793,442 bp, with 44.27% GC content, 3,053 proteins, 3,169 genes, and 15 genes that play an important role in acetic acid production.

View Article and Find Full Text PDF

A first-in-human clinical study of an allogenic iPSC-derived corneal endothelial cell substitute transplantation for bullous keratopathy.

Cell Rep Med

January 2025

Department of Ophthalmology, Keio University School of Medicine, Shinjuku-ku 160-8582, Tokyo, Japan; Department of Clinical Regenerative Medicine, Fujita Medical Innovation Center, Fujita Health University, Ota-ku, Tokyo 144-0041, Japan. Electronic address:

A first-in-human investigator-initiated clinical study of a corneal endothelial cell substitute (CLS001) derived from a clinical-grade induced pluripotent stem cell (iPSC) line shows improvement of visual acuity and corneal stromal edema, with no adverse events for up to 1 year after surgery for the treatment of bullous keratopathy. While preclinical tests, including multiple whole-genome analysis and tumorigenicity tests adhering to the Food and Drug Administration (FDA) draft guidelines, are negative, an additional whole-genome analysis conducted on transplanted CLS001 cells reveals a de novo in-frame deletion of exon22 in the EP300 gene. No adverse events related to the mutation are observed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!